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Developing a clinical research network: The Northern 
 Region Endoscopy Group experience
Research is central to the National Health Service. Clinical 
trial recruitment has been aided by the National Institute 
for Health Research’s Comprehensive Research Network but 
these networks do not support development of research. The 
Northern Region Endoscopy Group (NREG) was founded in 
2007, encompasses 17 endoscopy units and has become a 
highly successful collaborative research network. The network 
is now a major contributor to UK trials, has published over 
20 papers (>60 abstracts) and holds grants totalling more 
than £1.5 million. The NREG provides an exemplar model 
of how collaborative working can contribute signiﬁ cantly to 
biomedical research.
KEYWORDS: Network, research, collaboration, quality, National 
Institute for Health Research, NIHR, Northern Region Endoscopy 
Group
Background
The NHS is one of the largest organisations in the world and 
provides an ever-increasing range of services to its users. 
Maintaining and continually improving the quality and 
effi ciency of services provided within the NHS through 
research, audit and service improvement is crucial.1 There is 
often clinician enthusiasm but becoming involved in research 
can be daunting. The complexities of research along with 
the pressure of clinical workload can be a barrier. Many see 
research as the preserve of large institutions with strong 
academic backgrounds. In addition, many clinicians working in 
smaller units may have insuffi cient patient numbers or support 
to undertake meaningful research. The National Institute for 
Health Research (NIHR) Comprehensive Clinical Research 
Network (CCRN) has helped to increase research activity; 
however, the development of research studies falls outside its 
remit. Development of collaborative networks at a clinical level 
is essential to drive research forward within the NHS. 
This paper describes the model of the Northern Region 
Endoscopy Group (NREG), a highly successful clinical 
research network in the north of England. Since its inception 
in 2007, the NREG has established itself as one of the leaders in 
endoscopy research in the country, with a growing reputation 
internationally. The authors describe how this has been 
achieved and how this model could be replicated in other 
specialties and regions to complement the role of existing NHS 
research organisations.
Why develop a clinical research network? 
The NHS offers a unique environment in which to conduct 
research and has the potential to deliver outstanding work. 
Few countries can deliver the relative uniformity of care and 
standards provided by the NHS. The NHS should lead world 
biomedical research. Historically, the majority of NHS research 
has taken place in larger academic hospitals with very little led 
from smaller units. It may not be possible to generalise single 
centre or academic centre research because these units might 
not be representative of wider clinical care. Furthermore, as 
most patients are managed in district general hospitals, there are 
likely to be fewer opportunities to become involved in research.
The establishment of the NIHR in 2006, and subsequently the 
CCRN and comprehensive local research networks (CRLNs), 
has stimulated greater involvement in research in England. 
This has been achieved through the provision of support 
costs to NIHR-approved clinical research studies that are 
included in the NIHR CRN portfolio and through assistance 
in the local approvals process.2,3 Clinicians with research 
ideas, however, still face the challenge of obtaining funding, 
developing research protocols and gaining the appropriate 
approvals before commencing studies. In addition, non-NIHR-
funded research projects, as well as audit, service improvement 
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work and development of regional databases, all of which are 
important, are not within the remit of these organisations. 
Clinical research networks help bridge such gaps by providing 
complementary support to the NIHR in areas where it cannot 
currently offer assistance.4
Conducting research within a network allows large-scale, 
well-coordinated research studies to be performed, in contrast to 
multiple small studies that may not be reproducible. Networks 
also provide the opportunity for units of varied sizes to become 
involved in research, which consequently means that the results 
produced will be more generally applicable. Finally, clinical 
research networks allow research and other projects to be led 
from smaller units while providing the support and resources of 
larger centres, together with patient populations, thus developing 
and encouraging a research culture throughout the NHS.4
How to develop a clinical research network
The Northern Region Endoscopy Group was formed in 2007 
(joined by Leeds in 2012) with the aim of delivering a high-
quality, region-wide research, service improvement and 
audit projects. The area covered is shown in Fig 1. Regular 
meetings are open to all with an interest in and enthusiasm for 
endoscopic research. The group has a representative from each 
organisation within the region, with each unit’s link person 
acting as a representative for that unit, in addition to being 
able to disseminate the information back to their colleagues. 
Regardless of size, all units are accorded equal status. During 
meetings, new research ideas are proposed and developed, and 
updates given on projects that are under way. New projects 
are brought forward by an enthusiast who subsequently leads 
the study. Each project also has an individual steering group 
supported by the NREG committee.5
The NREG is an unoffi cial clinical research network from 
the perspective of the NIHR, although both the chair and the 
vice-chair are specialty group leads for their respective CLRNs. 
The group has terms of reference and is accountable to the 
committee, which has representation from each member trust. 
Initial resources included the time, enthusiasm and energy 
of the NREG’s founding members. Financial support was from 
industry, the strategic health authority (SHA) and the chair’s 
trust (South Tyneside Foundation Trust), who recognised the 
potential and early success of the NREG. This support was 
initially small and grew with the success of the group. 
NREG had two early aims: 
1 Clinically important region-wide audit projects 
and retrospective service evaluation work
The benefi t of this approach was demonstrating collaborative 
work, overcoming barriers together and producing rapid results 
in order to demonstrate the value to the service, encourage 
clinical engagement and establish a presence. This also led to 
publication of abstracts and full papers, thereby developing 
further enthusiasm and engagement. Educational events with 
high-profi le speakers further enhanced the reputation of the 
network.
2 Involvement in larger studies to increase experience 
of research and develop resources for further work
The NREG prioritised involvement and recruitment to 
established NIHR studies, encouraging region-wide engagement 
through promotion at NREG meetings. This also highlighted 
the potentially complex nature of prospective research studies 
and, therefore, the importance of collaboration with academic 
organisations and key opinion leaders with a track record of 
producing high-quality research. The NREG has developed 
a strong partnership with Durham University, along with 
close collaboration with other academic institutions (Imperial 
College, Leeds University) and centres of excellence in the UK 
and abroad. The NREG has also developed strong links with 
industry including testing prototype technology and techniques.
After the achievement of these early aims, the NREG focused 
on forming an infrastructure that would allow high-quality 
collaborative research projects to be developed both within the 
region and through external collaboration.
Developing research ideas
Development of a research idea from infancy through to a 
proposal suitable for a grant application requires a long iterative 
process. This involves discussion of ideas and constructive 
feedback, ideally from individuals of varied backgrounds 
and experience to enable all perspectives to be explored. This 
process is diffi cult to achieve within smaller units both due 
to the time constraints of clinical commitments and because 
the required expertise may not be available. The NREG has 
been able to provide an environment, through collaboration of 
regional clinical expertise and local academic units, in which 
research ideas can progress to gain funding. 
Research study support
Once funding has been secured the challenge of running a 
quality study begins. This initially consists of the development 
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Fig 1. Geographical area covered by the Northern Region Endoscopy 
Group.
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of a study protocol and documents, gaining ethical and 
local research and development (R&D) approval, followed 
by recruitment, monitoring, data analysis and report 
writing. The NIHR and CCRN provide support with the 
approvals process and encourage recruitment through its 
remuneration mechanism; however, they do not provide 
support in identifying and overcoming barriers to recruitment. 
Collaboration with academic units, specifi cally Durham 
University’s Clinical Trials Unit, has resulted in these 
processes being much smoother. Furthermore, local clinician 
collaboration allows region-wide study promotion and pooling 
of ideas on how improved recruitment can be achieved.
Barriers to success
Naturally there were some challenges during the initial 
period. These included delays in the local approvals processes, 
including diffi culties with access for non-trust employees, and 
for audit and service improvement projects that are outside the 
remit of the NIHR. Solutions consisted of good communication 
with R&D leads from the NREG chair to expedite these 
processes. Funding was initially limited and compensated for 
by the enthusiasm of NREG’s founding members. The NREG’s 
progress led to interest from both the SHA and industry. A 
signifi cant proportion of these initially limited resources was 
directed towards supporting recruitment to NIHR portfolio 
studies. Success in this area allowed funds to grow, facilitating 
further work. Engagement from member units was variable 
initially; however, buy-in has increased with promotion and 
on demonstration of the success of the model. The complexity 
of the NIHR structure, particularly with regard to the funding 
processes, was also an initial barrier. This was overcome 
through collaboration with those with experience of these 
systems, including academic units and Durham University.
What can a clinical research network achieve?
The NREG is the fi rst clinician-led research network of its kind in 
the UK and has provided an infrastructure in which enthusiastic 
individuals and units, regardless of size or reputation, present and 
develop ideas for research as well as encouraging involvement in 
established local and national studies. 
Early audit and service improvement work benefi ted clinical 
areas by playing a crucial role in improving the quality and 
effi ciency of the services evaluated, as well as increasing 
the profi le of these areas. The results of one study have also 
contributed to upcoming changes in the recommended national 
standards for colonoscopy performance.6 The work has also 
led to publications that played an important part in creating 
local enthusiasm and enhancing the national and international 
reputation of NREG. 
National gastrointestinal (GI) studies have benefi ted from 
NREG’s promotion in its member units, leading to the two 
CRLNs covered by the NREG providing the highest number 
of recruits (by population size) to GI projects in the country 
(Fig 2). This increased research activity has also benefi ted 
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Fig 2. UK comprehensive local research network recruitment ﬁ gures to gastrointestinal studies.
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patients who now have a greater opportunity to become 
involved in research studies that may not have previously been 
available. Furthermore, resources, as well as enthusiasm, were 
generated for the development of subsequent work.
The collaborative partnerships forged as a result of the work 
of the NREG have allowed clinicians to share resources and 
knowledge, and move more rapidly along the learning curve 
associated with starting a career in research. Many clinicians 
with research enthusiasm, but no prior track records in research, 
have been engaged. Before the establishment of the NREG 
there were no academic endoscopy appointments and only a 
handful of consultants recruiting to clinical trials. There are 
now four NREG consultants appointed to senior academic 
posts; several now hold grants and are leading their own studies, 
and approximately 25 are involved in trials as local principal 
investigators. Furthermore, non-endoscopic research studies in 
gastroenterology and hepatology are also promoted at NREG 
meetings, providing a stimulus for recruitment in these areas.
The successful development of academic links has led to 
several successful grant applications for both collaborative and 
NREG-led studies totalling approximately £1.5 million. The 
grants secured are summarised in Table 1. This has greatly 
benefi ted trainees in gastroenterology within the region 
through the creation of several clinical and research fellow 
posts, thereby increasing opportunities to become involved in 
a wide range of studies including research, audit and service 
evaluation work. The NREG has delivered a wide range of 
studies and there are currently six funded endoscopy research 
fellows working in the region on projects involving the NREG 
where before there were none. The studies, those working 
on each study and the product of each study to date, are 
summarised in Table 2.
The NREG has also played a role in attracting the endoscopy 
industry back to the UK for the evaluation of technology and 
research. This has led to investment in the NREG with several 
research fellows and nurses funded by industry. 
All research, service improvement and audit work must be 
performed with the aim of delivering the best possible care to 
patients. The service improvement and audit work performed 
by the NREG within the region has meant that patients have 
access to a higher-quality, more effi cient service. The work 
with primary care on barriers to uptake of bowel cancer 
screening has the potential to greatly improve understanding 
of why patients decline the invitation to participate and, 
therefore, to increase uptake by addressing these concerns. 
This has the potential to signifi cantly infl uence mortality and 
morbidity from this common disease. Finally, as a result of 
the increase in research activity, the opportunity for patients 
to become involved in research studies is ever increasing, no 
matter where their care is based.
An important factor in evaluating the NREG’s success is that 
most of it has been achieved with very little fi nancial outlay. 
The resources on which the NREG was based were the valuable 
time, expertise and enthusiasm of its founding members, and 
this remains vital to its continued success. The subsequent 
resources generated through recruitment to NIHR studies and 
successful grant applications, achieved through collaborations 
as discussed below, have allowed the group to succeed and grow. 
Collaboration
The key to the success of the NREG is inclusivity and 
collaboration. This was initially between local enthusiasts and, 
as the group developed, with regional, national and international 
academic units, clinical centres of excellence and key industry 
leaders. The growing reputation of the NREG is such that the 
group is frequently approached by national and international 
units wishing to collaborate on research studies (Table 2). 
Table 1. Grants currently held or co-held by the Northern Region Endoscopy Group (NREG).
Study Funding 
organisation
Amount 
secured
Grant holders
Barriers to Uptake of Colorectal Cancer Screening (2010) NIHR RfPB £45,000 CJ Rees, G Rubin, D Weller
SeAFOod (2010) NIHR EME £1.2 million M Hull, CJ Rees, R Logan et al
Quality Improvement in Colonoscopy (2010) SHA quality 
improvement grant
£52,000 CJ Rees, MD Rutter, JE East, BP Saunders
Biodegradable stent in benign oesophageal stricture 
compared to standard balloon dilatation treatment 
(BESST)
NIHR RfPB £120,000 A Dhar, CJ Rees, D Dwarkanath, A Reddy, 
YKS Vishwanath, JRG Greenaway, JM 
Mason
Detect Inspect Characterise Resect and Discard 
(DISCARD) 2 trial (2011)
NIHR RfPB £250,000 CJ Rees, A Ignatovic, H Close, JE East, BP 
Saunders, MD Rutter, J Mason
Barriers to Uptake of Flexible Sigmoidoscopy Screening Policy Research 
Unit, DH
£120,000 G Rubin, CJ Rees, N Hall, D Weller, J 
Wardle
Qualitative analysis of engagement with Quality 
Improvement in Colonoscopy
Olympus Medical 
Grant
£10,000 CJ Rees, JE East, BP Saunders, MD Rutter
North East Interval Cancer study 2 Charitable funds £20,000 CJ Rees, MD Gill, M Bradburn, S Mills, M 
Bramble, C Parker, TJW Lee, Y Bury, M Hull
DH = Department of Health; NIHR = National Institute for Health Research; NREG = Northern Region Endoscopy Group; RfPB = research for patient benefit; SeAFOod 
= Systematic Evaluation of Aspirin and Fish Oil; SHA = strategic health authority.
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Conclusion
The NREG has demonstrated rapid growth and development 
over a 5-year period. Many clinicians with research 
enthusiasm but no prior track records in research have been 
engaged. This has allowed involvement in endoscopy research 
for many and a research career for some. The growing 
reputation of the group has led to collaboration with many 
co-investigators throughout the UK and internationally. 
The NREG was initially established with few resources other 
than enthusiasm and hard work with the subsequent success 
generating resources and allowing the development of higher 
quality research and the group to fl ourish. The success of the 
NREG has also led to many invitations to talk to both GI and 
other specialty groups on how the group was developed and 
success achieved. The model is now being followed in other 
areas of the UK. We would strongly encourage other clinical 
groups to replicate this model and develop similar clinical 
research networks. ■
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